Natco Pharma Archives - Express Pharma

Alembic Pharma announces partner NATCO Pharma gets USFDA tentative nod for Olaparib tablets

Lupin, Natco receive US FDA approval for Eribulin Mesylate Injection

Eris Lifesciences partners Natco Pharma to commercialise Semaglutide in India

NATCO Pharma and Breckenridge launch Everolimus 1mg generic in the U.S. market

Natco to launch generic of Risdiplam for SMA patients

Walking the talk on ESG, workplace safety

NATCO Pharma offers to acquire stake in South African Adcock Ingram Holdings

US tariffs, IP issues threaten patient access

Indian biotech firm develops first indigenous bi-specific 3rd generation CAR T cells for cancer treatment

NATCO Canada announces $ 8 mn investment in eGenesis